Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Mizuho Reiterates Neutral on Satsuma Pharma, Maintains $2 Price Target

Author: Benzinga Newsdesk | March 30, 2023 07:26am

Mizuho analyst Uy Ear reiterates Satsuma Pharma (NASDAQ:STSA) with a Neutral and maintains $2 price target.

Posted In: STSA